Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Scuffham

Showing results (41-50 of 208) with videos related to

Pageof 21
Sort By:
Applied Health Economics and Health Policy|December 29, 2011
Insights from triangulation of two purchase choice elicitation methods to predict social decision making in healthcareJennifer A Whitty, Sharyn R Rundle-Thiele, Paul A Scuffham
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2019
Pediatric Quality of Life Instruments in Oral Health Research: A Systematic ReviewRuvini M Hettiarachchi, Sanjeewa Kularatna, Joshua Byrnes, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 10, 2014
Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling MethodsJennifer A Whitty, Julie Ratcliffe, Gang Chen, et al.
BMC Cardiovascular Disorders|May 3, 2013
Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)Erika Turkstra, Anna L Hawkes, Brian Oldenburg, et al.
Pharmacoeconomics|July 31, 2009
Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age groupAnthony T Newall, Heath Kelly, Stuart Harsley, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2011
Quality-of-life implications of immediate surgery and watchful waiting in asymptomatic aortic stenosis: a decision-analytic modelHemal Gada, Paul A Scuffham, Brian Griffin, et al.
Applied Health Economics and Health Policy|July 2, 2019
A Framework to Prioritise Health Research Proposals for Funding: Integrating Value for MoneyHaitham W Tuffaha, Joanne Aitken, Suzanne Chambers, et al.
The Patient|October 19, 2020
Utility Values for the CP-6D, a Cerebral Palsy-Specific Multi-Attribute Utility Instrument, Using a Discrete Choice ExperimentMina Bahrampour, Richard Norman, Joshua Byrnes, et al.
Health and Quality of Life Outcomes|September 28, 2013
Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri LankaSanjeewa Kularatna, Jennifer A Whitty, Newell W Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
Health state valuation in low- and middle-income countries: a systematic review of the literatureSanjeewa Kularatna, Jennifer A Whitty, Newell W Johnson, et al.
Pageof 21

Showing results (41-50 of 208) with videos related to

Sort By:
Pageof 21
Applied Health Economics and Health Policy|December 29, 2011
Insights from triangulation of two purchase choice elicitation methods to predict social decision making in healthcareJennifer A Whitty, Sharyn R Rundle-Thiele, Paul A Scuffham
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 22, 2019
Pediatric Quality of Life Instruments in Oral Health Research: A Systematic ReviewRuvini M Hettiarachchi, Sanjeewa Kularatna, Joshua Byrnes, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 10, 2014
Australian Public Preferences for the Funding of New Health Technologies: A Comparison of Discrete Choice and Profile Case Best-Worst Scaling MethodsJennifer A Whitty, Julie Ratcliffe, Gang Chen, et al.
BMC Cardiovascular Disorders|May 3, 2013
Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart)Erika Turkstra, Anna L Hawkes, Brian Oldenburg, et al.
Pharmacoeconomics|July 31, 2009
Cost effectiveness of influenza vaccination in older adults: a critical review of economic evaluations for the 50- to 64-year age groupAnthony T Newall, Heath Kelly, Stuart Harsley, et al.
Circulation. Cardiovascular Quality and Outcomes|September 1, 2011
Quality-of-life implications of immediate surgery and watchful waiting in asymptomatic aortic stenosis: a decision-analytic modelHemal Gada, Paul A Scuffham, Brian Griffin, et al.
Applied Health Economics and Health Policy|July 2, 2019
A Framework to Prioritise Health Research Proposals for Funding: Integrating Value for MoneyHaitham W Tuffaha, Joanne Aitken, Suzanne Chambers, et al.
The Patient|October 19, 2020
Utility Values for the CP-6D, a Cerebral Palsy-Specific Multi-Attribute Utility Instrument, Using a Discrete Choice ExperimentMina Bahrampour, Richard Norman, Joshua Byrnes, et al.
Health and Quality of Life Outcomes|September 28, 2013
Study protocol for valuing EQ-5D-3L and EORTC-8D health states in a representative population sample in Sri LankaSanjeewa Kularatna, Jennifer A Whitty, Newell W Johnson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 18, 2013
Health state valuation in low- and middle-income countries: a systematic review of the literatureSanjeewa Kularatna, Jennifer A Whitty, Newell W Johnson, et al.
Pageof 21